Functional multipotency of stem cells: What do we need from them in the heart?

Stem Cells International

Volumn , Issue , 2012, Pages

  Díez Villanueva, Pablo ^a   Sanz Ruiz, Ricardo ^a   Núñez García, Alberto ^a   Fernández Santos, María Eugenia ^a   Sánchez, Pedro L ^a   Fernández Avilés, Francisco ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE DERIVED STEM CELL; ADULT STEM CELL; ARTICLE; BONE MARROW CELL; CARDIAC STEM CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL RENEWAL; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHRONIC DISEASE; EMBRYONIC STEM CELL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; MOLECULAR DYNAMICS; MULTIPOTENT STEM CELL; MYOBLAST; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION; THERAPY EFFECT; TREATMENT PLANNING; UMBILICAL CORD BLOOD;

EID: 84866234067     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2012/817364     Document Type: Article

References (81)

1. Boyle A. J., Schulman S. P., Hare J. M., Stem cell therapy for cardiac repair: ready for the next step. Circulation 2006 114 4 339 352 2-s2.0-33748069125 10.1161/CIRCULATIONAHA.105.590653 (Pubitemid 44297100)
2. Sánchez P. L., Villa A., Sanz R., Domínguez M., Ludwig I., Fernández M. E., Fernández-Avilés F., Present and future of stem cells for cardiovascular therapy. Annals of Medicine 2007 39 6 412 427 2-s2.0-34748880046 10.1080/07853890701513746 (Pubitemid 47479266)
3. El Fahime E., Tremblay J. P., Dib N., Taylor D. A., Diethrich E. B., Myocardial regeneration: which cell and why. Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair. From Basic Research to Clinical Applications 2006 Springer Science 25 31
4. Rosenzweig A., Cardiac cell therapymixed results from mixed cells. The New England Journal of Medicine 2006 355 12 1274 1277 2-s2.0-33748896774 10.1056/NEJMe068172 (Pubitemid 44427452)
5. Wollert K. C., Drexler H., Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nature Reviews Cardiology 2010 7 4 204 215 2-s2.0-77950300420 10.1038/nrcardio.2010.1
6. Chavakis E., Koyanagi M., Dimmeler S., Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. Circulation 2010 121 2 325 335 2-s2.0-74949106772 10.1161/CIRCULATIONAHA.109.901405
7. Perin E. C., Silva G. V., Perin C. E., Silva G. V., Willerson T. J., What are stem cells and what do they do? An Essential Guide to Cardiac Cell Therapy 2006 Informa Healthcare 3 12
8. Williams J. M., Petersen B. E., Olmo D. G., García-Verdugo J. M., Alemany J., Gutiérrez-Fuente J. A., Origin, evolution, and direction of human somatic cell therapy. Cell Therapy 2008 McGraw Hill-Interamericana 3 14
9. Verfaille M. Serafini and C. M., Olmo D. G., García-Verdugo J. M., Alemany J., Gutiérrez-Fuente J. A., Multipotent progenitor cell populations obtained from bone marrow. Cell Therapy 2008 McGraw Hill-Interamericana 89 102
10. Verfaillie C. M., Pera M. F., Lansdorp P. M., Stem cells: hype and reality. Hematology 2002 369 391 2-s2.0-1842858314
11. Jiang Y., Jahagirdar B. N., Reinhardt R. L., Schwartz R. E., Keene C. D., Ortiz-Gonzalez X. R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W. C., Lergaespada D. A., Verfaillie C. M., Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002 418 6893 41 49 2-s2.0-0037019337 10.1038/nature00870 (Pubitemid 34742565)
12. Soler-Botija C., Cervera R. P., Izpisúa J. C., Olmo D. G., García-Verdugo J. M., Alemany J., Gutiérrez-Fuente A., The biology of tissue and organ regeneration. Cell Therapy 2008 McGraw Hill-Interamericana 15 32
13. Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman M. A., Simonetti D. W., Craig S., Marshak D. R., Multilineage potential of adult human mesenchymal stem cells. Science 1999 284 5411 143 147 2-s2.0-0033515827 10.1126/science.284.5411.143 (Pubitemid 29282067)
14. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F. C., Krause D. S., Deans R. J., Keating A., Prockop D. J., Horwitz E. M., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006 8 4 315 317 2-s2.0-33747713246 10.1080/14653240600855905 (Pubitemid 44269669)
15. Theise N. D., Stem cell plasticity: recapping the decade, mapping the future. Experimental Hematology 2010 38 7 529 539 2-s2.0-77953487298 10.1016/j.exphem.2010.04.013
16. Quaini F., Urbanek K., Beltrami A. P., Finato N., Beltrami C. A., Nadal-Ginard B., Kajstura J., Leri A., Anversa P., Chimerism of the transplanted heart. The New England Journal of Medicine 2002 346 1 5 15 2-s2.0-0037012139 10.1056/NEJMoa012081 (Pubitemid 34438914)
17. Laflamme M. A., Myerson D., Saffitz J. E., Murry C. E., Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circulation Research 2002 90 6 634 640 2-s2.0-0037023632 10.1161/01.RES.0000014822.62629.EB (Pubitemid 34640880)
18. Perin E., Silva G. V., Stem cell therapy for cardiac diseases. Current Opinion in Hematology 2004 11 309 403
19. Herzog E. L., Chai L., Krause D. S., Plasticity of marrow-derived stem cells. Blood 2003 102 10 3483 3493 2-s2.0-0242495039 10.1182/blood-2003-05-1664 (Pubitemid 37409363)
20. Zhang S., Wang D., Estrov Z., Raj S., Willerson J. T., Yeh E. T. H., Kloner R. A., Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 2004 110 25 3803 3807 2-s2.0-11144342747 10.1161/01.CIR.0000150796.18473.8E (Pubitemid 40023979)
21. Prockop D. J., Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997 276 5309 71 74 2-s2.0-0030889354 10.1126/science.276.5309. 71 (Pubitemid 27161245)
22. Blau H. M., A twist of fate. Nature 2002 419 6906 437 2-s2.0-0037015601 10.1038/419347a
23. Wurmser A. E., Gage F. H., Stem cells: cell fusion causes confusion. Nature 2002 416 6880 485 487 2-s2.0-0037041406 10.1038/416485a (Pubitemid 34288836)
24. Sanz-Ruiz R., Gutiérrez Ibañes E., Arranz A. V., Fernández Santos M. E., Fernández P. L. S., Fernández- Avilés F., Phases I-III clinical trials using adult stem cells. Stem Cells International 2010 2010 12 2-s2.0-79959401934 10.4061/2010/579142 579142
25. Prosper F., Olmo D. G., García-Verdugo J. M., Alemany J., Gutiérrez-Fuente A., Therapeutic potential of cells from non-marrow postnatal cells. Cell Therapy 2008 McGraw Hill-Interamericana 103 112
26. Harraz M., Jiao C., Hanlon H. D., Hartley R. S., Schatteman G. C., Cd34- blood-derived human endothelial cell progenitors. Stem Cells 2001 19 4 304 312 2-s2.0-0034904922 (Pubitemid 32721097)
27. Fernandez Pujol B., Lucibello F. C., Gehling U. M., Lindemann K., Weidner N., Zuzarte M. L., Adamkiewicz J., Elsässer H. P., Müller R., Havemann K., Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 2000 65 5 287 300 2-s2.0-0034130392 (Pubitemid 30406634)
28. Schmeisser A., Garlichs C. D., Zhang H., Eskafi S., Graffy C., Ludwig J., Strasser R. H., Daniel W. G., Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovascular Research 2001 49 3 671 680 2-s2.0-0035895774 10.1016/S0008-6363(00)00270-4 (Pubitemid 32146430)
29. Oettgen P., Cardiac stem cell therapy: need for optimization of efficacy and safety monitoring. Circulation 2006 114 4 353 358 2-s2.0-33748059545 10.1161/CIRCULATIONAHA.106.639385 (Pubitemid 44297101)
30. Anversa P., Nadal-Ginard B., Myocyte renewal and ventricular remodelling. Nature 2002 415 6868 240 243 2-s2.0-0037049990 10.1038/415240a (Pubitemid 34059531)
31. Rumpold H., Wolf D., Koeck R., Gunsilius E., Endothelial progenitor cells: a source for therapeutic vasculogenesis? Journal of Cellular and Molecular Medicine 2004 8 4 509 518 2-s2.0-16644395659 (Pubitemid 44145483)
32. Jiang J., Han P., Zhang Q., Zhao J., Ma Y., Cardiac differentiation of human pluripotent stem cells. Journal of Cellular and Molecular Medicine 2012 16 8 1663 1668
33. Menasché P., Stem cell therapy for heart failure: are arrhythmias a real safety concern? Circulation 2009 119 20 2735 2740 2-s2.0-67249096636 10.1161/CIRCULATIONAHA.108.812693
34. Virmani R., Kolodgie F. D., Ladich E., Emerson Perin C., Guilherme Silva V., James Willerson T., Mechanistic insights into cardiac stem cell therapy from a histopathologic perspective. An Essential Guide to Cardiac Cell Therapy. Informa Healthcare 2006 43 54
35. Kocher A. A., Schuster M. D., Szabolcs M. J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N. M., Itescu S., Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine 2001 7 4 430 436 2-s2.0-0035044085 10.1038/86498 (Pubitemid 32298545)
36. Yoon Y. S., Wecker A., Heyd L., Park J. S., Tkebuchava T., Kusano K., Hanley A., Scadova H., Qin G., Cha D. H., Johnson K. L., Aikawa R., Asahara T., Losordo D. W., Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. Journal of Clinical Investigation 2005 115 2 326 338 2-s2.0-20144362576 10.1172/JCI200522326 (Pubitemid 40385474)
37. Semedo P., Burgos-Silva M., Donizetti-Oliveira C., Saraiva Camara N. O., Gholamrezanezhad A., How do mesenchymal stem cells repair? Stem Cells in Clinic and Research 2011 Intech 83 94
38. Pittenger M. F., Martin B. J., Mesenchymal stem cells and their potential as cardiac therapeutics. Circulation Research 2004 95 1 9 20 2-s2.0-3142663241 10.1161/01.RES.0000135902.99383.6f (Pubitemid 38931831)
39. Toma C., Pittenger M. F., Cahill K. S., Byrne B. J., Kessler P. D., Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002 105 1 93 98 2-s2.0-0036142213 10.1161/hc0102.101442 (Pubitemid 34049148)
40. Gnecchi M., Danieli P., Cervio E., Mesenchymal stem cell therapy for heart disease. Vascular Pharmacology 2012 57 48 55
41. Karama J. P., Muscari C., Montero-Menei C. N., Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. Biomaterials 2012 33 5683 5695
42. Bergmann O., Bhardwaj R. D., Bernard S., Zdunek S., Barnabé-Heide F., Walsh S., Zupicich J., Alkass K., Buchholz B. A., Druid H., Jovinge S., Frisén J., Evidence for cardiomyocyte renewal in humans. Science 2009 324 5923 98 102 2-s2.0-64249107059 10.1126/science.1164680
43. Balmer G. M., Riley P. R., Harnessing the potential of adult cardiac stem cells: lessons from haematopoiesis, the embryo and the niche. Journal of Cardiovascular Translational Research. In press
44. Beltrami A. P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., Anversa P., Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003 114 6 763 776 2-s2.0-10744228523 10.1016/S0092-8674(03)00687-1 (Pubitemid 37186770)
45. Urbanek K., Torella D., Sheikh F., De Angelis A., Nurzynska D., Silvestri F., Beltrami C. A., Bussani R., Beltrami A. P., Quaini F., Bolli R., Leri A., Kajstura J., Anversa P., Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proceedings of the National Academy of Sciences of the United States of America 2005 102 24 8692 8697 2-s2.0-20844447692 10.1073/pnas.0500169102 (Pubitemid 40862797)
46. Gambini E., Pesce M., Persico L., Patient profile modulates cardiac c-kit1 progenitor cell availability and amplification potential. Translational Research. In press
47. Ma N., Stamm C., Kaminski A., Li W., Kleine H. D., Müller-Hilke B., Zhang L., Ladilov Y., Egger D., Steinhoff G., Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovascular Research 2005 66 1 45 54 2-s2.0-20144380166 10.1016/j.cardiores.2004.12.013 (Pubitemid 40357867)
48. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007 131 5 861 872 2-s2.0-36248966518 10.1016/j.cell.2007.11.019 (Pubitemid 350138099)
49. Yu J., Vodyanik M. A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J. L., Tian S., Nie J., Jonsdottir G. A., Ruotti V., Stewart R., Slukvin I. I., Thomson J. A., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007 318 5858 1917 1920 2-s2.0-36749043230 10.1126/science. 1151526
50. Nelson T. J., Martinez-Fernandez A., Yamada S., Perez-Terzic C., Ikeda Y., Terzic A., Repair of acute myocardial infarction with induced pluripotent stem cells induced by human stemness factors. Circulation 2009 120 5 408 416 2-s2.0-68249094138 10.1161/CIRCULATIONAHA.109.865154
51. Wei H., Tan G., Manasi, One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Research 2012 9 87 100
52. Singla D. K., Long X., Glass C., Singla R. D., Yan B., pluripotent stem (iPS) cells repair and regenerate infarcted myocardium. Molecular Pharmacology 2011 8 1573 1581
53. Forrester J. S., Price M. J., Makkar R. R., Stem cell repair of infarcted myocardium: an overview for clinicians. Circulation 2003 108 9 1139 1145 2-s2.0-0042316981 10.1161/01.CIR.0000085305.82019.65 (Pubitemid 37071527)
54. Schächinger V., Erbs S., Elsässer A., Haberbosch W., Hambrecht R., Hölschermann H., Yu J., Corti R., Mathey D. G., Hamm C. W., Süselbeck T., Assmus B., Tonn T., Dimmeler S., Zeiher A. M., Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine 2006 355 12 1210 1221 2-s2.0-33748910402 10.1056/NEJMoa060186 (Pubitemid 44427445)
55. Wollert K. C., Meyer G. P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., Arseniev L., Hertenstein B., Ganser A., Drexler H., Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. The Lancet 2004 364 9429 141 148 2-s2.0-3042710733 10.1016/S0140-6736(04) 16626-9 (Pubitemid 38891685)
56. Huikuri H. V., Kervinen K., Niemelä M., Ylitalo K., Säily M., Koistinen P., Savolainen E. R., Ukkonen H., Pietilä M., Airaksinen J. K. E., Knuuti J., Mäkikallio T. H., Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. European Heart Journal 2008 29 22 2723 2732 2-s2.0-56449121207 10.1093/eurheartj/ehn436
57. + cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. European Heart Journal 2009 30 11 1313 1321 2-s2.0-67649657795 10.1093/eurheartj/ehp073
58. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., Endresen K., Ilebekk A., Mangschau A., Fjeld J. G., Smith H. J., Taraldsrud E., Grogaard H. K., Bjornerheim R., Brekke M., Müller C., Hopp E., Ragnarsson A., Brinchmann J. E., Forfang K., Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. The New England Journal of Medicine 2006 355 12 1199 1209 2-s2.0-33748899627 10.1056/NEJMoa055706 (Pubitemid 44427444)
59. van der Laan A. M., Hirsch A., Nijveldt R., Van Der Vleuten P. A., Van Der Giessen W. J., Doevendans P. A., Waltenberger J., Ten Berg J. M., Aengevaeren W. R. M., Zwaginga J. J., Biemond B. J., Van Rossum A. C., Tijssen J. G. P., Zijlstra F., Piek J. J., Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Netherlands Heart Journal 2008 16 12 436 439 2-s2.0-58149236689
60. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., Kalantzi M., Herbots L., Sinnaeve P., Dens J., Maertens J., Rademakers F., Dymarkowski S., Gheysens O., Van Cleemput J., Bormans G., Nuyts J., Belmans A., Mortelmans L., Boogaerts M., Van De Werf F., Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. The Lancet 2006 367 9505 113 121 2-s2.0-30444432961 10.1016/S0140-6736(05)67861-0 (Pubitemid 43077127)
61. Chen S. L., Fang W. W., Ye F., Liu Y. H., Qian J., Shan S. J., Zhang J. J., Chunhua R. Z., Liao L. M., Lin S., Sun J. P., Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. American Journal of Cardiology 2004 94 1 92 95 2-s2.0-3042662157 10.1016/j.amjcard.2004.03.034 (Pubitemid 38813459)
62. Hare J. M., Traverse J. H., Henry T. D., Dib N., Strumpf R. K., Schulman S. P., Gerstenblith G., DeMaria A. N., Denktas A. E., Gammon R. S., Hermiller J. B., Reisman M. A., Schaer G. L., Sherman W., A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after acute myocardial infarction. Journal of the American College of Cardiology 2009 54 24 2277 2286 2-s2.0-70549103270 10.1016/j.jacc.2009.06.055
63. Ince H., Petzsch M., Kleine H. D., Schmidt H., Rehders T., Körber T., Schümichen C., Freund M., Nienaber C. A., Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 2005 112 20 3097 3106 2-s2.0-30944433575 10.1161/CIRCULATIONAHA.105.541433 (Pubitemid 43113441)
64. Leone A. M., Galiuto L., Garramone B., Rutella S., Giannico M. B., Brugaletta S., Perfetti M., Liuzzo G., Porto I., Burzotta F., Niccoli G., Biasucci L. M., Leone G., Rebuzzi A. G., Crea F., Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (The Rigenera Study). American Journal of Cardiology 2007 100 3 397 403 2-s2.0-34447622516 10.1016/j.amjcard.2007.03.036 (Pubitemid 47094686)
65. Takano H., Hasegawa H., Kuwabara Y., Nakayama T., Matsuno K., Miyazaki Y., Yamamoto M., Fujimoto Y., Okada H., Okubo S., Fujita M., Shindo S., Kobayashi Y., Komiyama N., Takekoshi N., Imai K., Himi T., Ishibashi I., Komuro I., Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction. International Journal of Cardiology 2007 122 1 41 47 2-s2.0-34848876386 10.1016/j.ijcard.2006.11.016 (Pubitemid 47503345)
66. Kang H. J., Kim H. S., Zhang S. Y., Park K. W., Cho H. J., Koo B. K., Kim Y. J., Lee D. S., Sohn D. W., Han K. S., Oh B. H., Lee M. M., Park Y. B., Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. The Lancet 2004 363 9411 751 756 2-s2.0-12144286350 10.1016/S0140-6736(04)15689-4 (Pubitemid 38315164)
67. Kang H. J., Lee H. Y., Na S. H., Chang S. A., Park K. W., Kim H. K., Kim S. Y., Chang H. J., Lee W., Kang W. J., Koo B. K., Kim Y. J., Lee D. S., Sohn D. W., Han K. S., Oh B. H., Park Y. B., Kim H. S., Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC cell-3-DES randomized, controlled trial. Circulation 2006 114 1 I145 I151 2-s2.0-33747181677 10.1161/CIRCULATIONAHA.105.001107 (Pubitemid 44297143)
68. Menasché P., Alfieri O., Janssens S., McKenna W., Reichenspurner H., Trinquart L., Vilquin J. T., Marolleau J. P., Seymour B., Larghero J., Lake S., Chatellier G., Solomon S., Desnos M., Hagège A. A., The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008 117 9 1189 1200 2-s2.0-41149106402 10.1161/CIRCULATIONAHA.107.734103 (Pubitemid 351552018)
69. Dib N., Michler R. E., Pagani F. D., Wright S., Kereiakes D. J., Lengerich R., Binkley P., Buchele D., Anand I., Swingen C., Di Carli M. F., Thomas J. D., Jaber W. A., Opie S. R., Campbell A., McCarthy P., Yeager M., Dilsizian V., Griffith B. P., Korn R., Kreuger S. K., Ghazoul M., MacLellan W. R., Fonarow G., Eisen H. J., Dinsmore J., Diethrich E., Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005 112 12 1748 1755 2-s2.0-25444462742 10.1161/CIRCULATIONAHA.105.547810 (Pubitemid 41368151)
70. Assmus B., Honold J., Schächinger V., Britten M. B., Fischer-Rasokat U., Lehmann R., Teupe C., Pistorius K., Martin H., Abolmaali N. D., Tonn T., Dimmeler S., Zeiher A. M., Transcoronary transplantation of progenitor cells after myocardial infarction. The New England Journal of Medicine 2006 355 12 1222 1232 2-s2.0-33748899449 10.1056/NEJMoa051779 (Pubitemid 44427446)
71. Strauer B. E., Yousef M., Schannwell C. M., The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study. European Journal of Heart Failure 2010 12 7 721 729 2-s2.0-77954924609 10.1093/eurjhf/hfq095
72. Makkar R. R., Smith R. R., Cheng K., Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. The Lancet 2012 379 895 904
73. Bolli R., Chugh A. R., D'Amario D., stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. The Lancet 2011 378 1847 1857
74. Tse H. F., Thambar S., Kwong Y. L., Rowlings P., Bellamy G., McCrohon J., Thomas P., Bastian B., Chan J. K. F., Lo G., Ho C. L., Chan W. S., Kwong R. Y., Parker A., Hauser T. H., Chan J., Fong D. Y. T., Lau C. P., Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). European Heart Journal 2007 28 24 2998 3005 2-s2.0-37249084757 10.1093/eurheartj/ehm485 (Pubitemid 350262782)
75. van Ramshorst J., Bax J. J., Beeres S. L. M. A., Dibbets-Schneider P., Roes S. D., Stokkel M. P. M., De Roos A., Fibbe W. E., Zwaginga J. J., Boersma E., Schalij M. J., Atsma D. E., Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. Journal of the American Medical Association 2009 301 19 1997 2004 2-s2.0-65649129319 10.1001/jama.2009.685
76. Richardson J. D., Nelson A. J., Zannettino A. C. W., Gronthos S., Worthley S. G., Psaltis P. J., Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. Stem Cell Reviews. In press
77. Giraud M.-N., Guex A. G., Tevaearai H. T., Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies. Cardiology Research and Practice 2012 2012 971614
78. Mohsin S., Siddiqi S., Collins B., Sussman M. A., Empowering adult stem cells for myocardial regeneration. Circulation Research 2011 109 1415 1428
79. Dong F., Harvey J., Finan A., Weber V. K., Agarwal U., Penn M., Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction. Circulation 2012 126 314 324
80. Dai B., Huang W., Xu M., Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function. American College of Cardiology 2011 58 2118 2127
81. Cho H. J., Lee H. J., Youn S. W., Secondary sphere formation enhances the functionality of cardiac progenitor cells. Molecular Therapy. In press 10.1038/mt.2012.109